Completed OBSERVATIONAL NCT03447028

Effect of TyG Index on Outcomes of Radical Prostatectomy (TyG-PCa)

A Novel Prognostic Risk Factor for Patients Undergoing Radical Prostatectomy: Triglyseride-Glucose (TyG) Index

Sponsor: Recep Tayyip Erdogan University Training and Research Hospital

Conditions Insulin Resistance Metabolic Syndrome Prostate Cancer

Updated 6 times since 2018 Last updated: Feb 24, 2018 Started: Jan 1, 2007 Primary completion: Dec 30, 2012 Completion: Dec 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Insulin Resistance and Metabolic Syndrome, this trial is completed. The trial is conducted by Recep Tayyip Erdogan University Training and Research Hospital and has accumulated 6 data snapshots since 2007. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 1 earlier version

Mar 2018 — Apr 2018 [monthly]

Completed NA

First recorded

Jan 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Recep Tayyip Erdogan University Training and Research Hospital

Data source: Recep Tayyip Erdogan University Training and Research Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.